NCT06819839

Brief Summary

The goal of this study is to test a village health worker (VHW) based care model to reduce cardiovascular risk among adults in areas of eastern Myanmar affected by armed conflict. All individuals aged 40 years and above will be invited to participate in this study. Participants will be checked whether they have a history of cardiovascular disease, diabetes (high blood sugar), high blood pressure or risk of developing cardiovascular disease by asking for medical history, measuring blood pressure, weight and height, and blood glucose if necessary. The main question the study aims to answer is: Does villagers residing in the VHW supported villages have their blood pressure controlled, adherent to therapy and subsequently reduce the risk of developing cardiovascular disease after 5 months of monthly VHW home visits?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
213

participants targeted

Target at P50-P75 for not_applicable cardiovascular-diseases

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable cardiovascular-diseases

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 27, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 25, 2025

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 11, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

July 31, 2025

Status Verified

December 1, 2024

Enrollment Period

6 months

First QC Date

January 25, 2025

Last Update Submit

July 29, 2025

Conditions

Keywords

Cardiovascular disease (CVD)Village health workerEastern MyanmarHypertensionDiabetesCare delivery model

Outcome Measures

Primary Outcomes (1)

  • Change in medication adherence - self-reported MARS-5

    Proportion of individuals adherent to evidence-based medications (taking the medication within the past 2 weeks, from self-report), AND a medication adherence report scale (MARS-5) adherence score of at least 16 out of 25. Requires taking at least one medication from each of the classes for which the individual is eligible: anti-hypertensive medication for individuals with hypertension, and statin for individuals with a history of ischemic heart disease, history of stroke, diabetes or 10-year CVD risk \>10%.

    5 months

Secondary Outcomes (56)

  • Change in medication adherence - self reported high

    5 months

  • Change in medication adherence - lenient

    5 months

  • Change in population level adherence

    5 months

  • Change in adherence to blood pressure medication

    5 months

  • Change in adherence to statin medication

    5 months

  • +51 more secondary outcomes

Study Arms (2)

Village Health Worker (VHW) Care Model

EXPERIMENTAL

7 villages are randomly selected and people (40 years and above) with increased cardiovascular disease risk receive VHW Care

Behavioral: Village Health Worker (VHW) Care Model

Standard Community Care

NO INTERVENTION

6 control villages randomly selected from 6 matched pairs and triplets of villages, and conduct a baseline and endline survey

Interventions

VHW care model includes four components: (1) universal screening of all non-pregnant adults over 40 for elevated CVD risk (2) confirmatory visit to confirm diagnoses of hypertension, diabetes and elevated CVD risk (predicted 10-year risk \>10%) (3) monthly household visits by VHW; (4) an mHealth tool (tablet computer) to assist with determination of study eligibility and provide recommendations for initiation of medications according to local guidelines. VHW household visits include: health education on smoking cessation, healthy diet, physical activity and medication adherence; assessment of possible medication side effects, measurement of blood pressure and (when applicable) blood glucose; review monitoring results with the treating clinician household delivery of medications; and facilitate referral and transport to higher levels of care.

Village Health Worker (VHW) Care Model

Eligibility Criteria

Age40 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 40 years or older
  • Current resident of study villages
  • No previous history of screening during the feasibility study a year ago
  • At least one CVD risk factor

You may not qualify if:

  • \- Currently pregnant or within three months postpartum

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Community Partners International

Hpa-An, Kayin State, Burma

Location

Related Publications (27)

  • Nagamine Y, Shobugawa Y, Sasaki Y, Takagi D, Fujiwara T, Khin YP, Nozaki I, Shirakura Y, Kay Thi L, Poe Ei Z, Thae Z, Win HH. Associations between socioeconomic status and adherence to hypertension treatment among older adults in urban and rural areas in Myanmar: a cross-sectional study using baseline data from the JAGES in Myanmar prospective cohort study. BMJ Open. 2023 Jan 17;13(1):e065370. doi: 10.1136/bmjopen-2022-065370.

    PMID: 36653052BACKGROUND
  • Lloyd-Jones DM, Huffman MD, Karmali KN, Sanghavi DM, Wright JS, Pelser C, Gulati M, Masoudi FA, Goff DC Jr. Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of Cardiology. Circulation. 2017 Mar 28;135(13):e793-e813. doi: 10.1161/CIR.0000000000000467. Epub 2016 Nov 4.

    PMID: 27815375BACKGROUND
  • Kaur G, Chauhan AS, Prinja S, Teerawattananon Y, Muniyandi M, Rastogi A, Jyani G, Nagarajan K, Lakshmi P, Gupta A, Selvam JM, Bhansali A, Jain S. Cost-effectiveness of population-based screening for diabetes and hypertension in India: an economic modelling study. Lancet Public Health. 2022 Jan;7(1):e65-e73. doi: 10.1016/S2468-2667(21)00199-7. Epub 2021 Nov 12.

    PMID: 34774219BACKGROUND
  • Basu S, Wagner RG, Sewpaul R, Reddy P, Davies J. Implications of scaling up cardiovascular disease treatment in South Africa: a microsimulation and cost-effectiveness analysis. Lancet Glob Health. 2019 Feb;7(2):e270-e280. doi: 10.1016/S2214-109X(18)30450-9. Epub 2018 Dec 6.

    PMID: 30528531BACKGROUND
  • Brownell NK, Ziaeian B, Jackson NJ, Richards AK. Trends in Income Inequities in Cardiovascular Health Among US Adults, 1988-2018. Circ Cardiovasc Qual Outcomes. 2024 May;17(5):e010111. doi: 10.1161/CIRCOUTCOMES.123.010111. Epub 2024 Apr 3.

    PMID: 38567505BACKGROUND
  • Patel A, Praveen D, Maharani A, Oceandy D, Pilard Q, Kohli MPS, Sujarwoto S, Tampubolon G. Association of Multifaceted Mobile Technology-Enabled Primary Care Intervention With Cardiovascular Disease Risk Management in Rural Indonesia. JAMA Cardiol. 2019 Oct 1;4(10):978-986. doi: 10.1001/jamacardio.2019.2974.

    PMID: 31461123BACKGROUND
  • Schwalm JD, McCready T, Lopez-Jaramillo P, Yusoff K, Attaran A, Lamelas P, Camacho PA, Majid F, Bangdiwala SI, Thabane L, Islam S, McKee M, Yusuf S. A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial. Lancet. 2019 Oct 5;394(10205):1231-1242. doi: 10.1016/S0140-6736(19)31949-X. Epub 2019 Sep 2.

    PMID: 31488369BACKGROUND
  • Jafar TH, Jehan I, de Silva HA, Naheed A, Gandhi M, Assam P, Finkelstein EA, Quigley HL, Bilger M, Khan AH, Clemens JD, Ebrahim S, Turner EL; for COBRA-BPS Study Group; Kasturiratne A. Multicomponent intervention versus usual care for management of hypertension in rural Bangladesh, Pakistan and Sri Lanka: study protocol for a cluster randomized controlled trial. Trials. 2017 Jun 12;18(1):272. doi: 10.1186/s13063-017-2018-0.

    PMID: 28606184BACKGROUND
  • Jafar TH, Gandhi M, de Silva HA, Jehan I, Naheed A, Finkelstein EA, Turner EL, Morisky D, Kasturiratne A, Khan AH, Clemens JD, Ebrahim S, Assam PN, Feng L; COBRA-BPS Study Group. A Community-Based Intervention for Managing Hypertension in Rural South Asia. N Engl J Med. 2020 Feb 20;382(8):717-726. doi: 10.1056/NEJMoa1911965.

    PMID: 32074419BACKGROUND
  • Patenaude B, Odihi D, Sriudomporn S, Mak J, Watts E, de Broucker G. A standardized approach for measuring multivariate equity in vaccination coverage, cost-of-illness, and health outcomes: Evidence from the Vaccine Economics Research for Sustainability & Equity (VERSE) project. Soc Sci Med. 2022 Jun;302:114979. doi: 10.1016/j.socscimed.2022.114979. Epub 2022 Apr 16.

    PMID: 35462106BACKGROUND
  • Chakraborty NM, Fry K, Behl R, Longfield K. Simplified Asset Indices to Measure Wealth and Equity in Health Programs: A Reliability and Validity Analysis Using Survey Data From 16 Countries. Glob Health Sci Pract. 2016 Mar 25;4(1):141-54. doi: 10.9745/GHSP-D-15-00384. Print 2016 Mar.

    PMID: 27016550BACKGROUND
  • Eddy DM, Adler J, Morris M. The 'Global Outcomes Score': a quality measure, based on health outcomes, that compares current care to a target level of care. Health Aff (Millwood). 2012 Nov;31(11):2441-50. doi: 10.1377/hlthaff.2011.1274.

    PMID: 23129674BACKGROUND
  • Spetz K, Olbers T, Ostbring M, Moon Z, Horne R, Andersson E. Using the 5-Item Medication Adherence Report Scale (MARS-5) to Screen for Non-adherence to Vitamin and Mineral Supplementation After Bariatric Surgery. Obes Surg. 2024 Feb;34(2):576-582. doi: 10.1007/s11695-023-07027-x. Epub 2024 Jan 4.

    PMID: 38177555BACKGROUND
  • Chan AHY, Horne R, Hankins M, Chisari C. The Medication Adherence Report Scale: A measurement tool for eliciting patients' reports of nonadherence. Br J Clin Pharmacol. 2020 Jul;86(7):1281-1288. doi: 10.1111/bcp.14193. Epub 2020 May 18.

    PMID: 31823381BACKGROUND
  • Richards A. Cardiovascular risk in hypertension: open questions about HOPE 4. Lancet. 2020 Aug 1;396(10247):310. doi: 10.1016/S0140-6736(20)30613-9. No abstract available.

    PMID: 32738948BACKGROUND
  • Wagstaff A. Inequality aversion, health inequalities and health achievement. J Health Econ. 2002 Jul;21(4):627-41. doi: 10.1016/s0167-6296(02)00006-1.

    PMID: 12146594BACKGROUND
  • Diabetes Project of Department of Public Health. Report on National Survey of Diabetes Mellitius and Risk Factors for Non-communicable Diseases in Myanmar (2014). Myanmar: Myanmar Ministry of Health and Sports, 2014.

    BACKGROUND
  • Naing C, Aung K. Prevalence and risk factors of hypertension in myanmar: a systematic review and meta-analysis. Medicine (Baltimore). 2014 Nov;93(21):e100. doi: 10.1097/MD.0000000000000100.

    PMID: 25380081BACKGROUND
  • Zaw KK, Nwe N, Hlaing SS. Prevalence of cardiovascular morbidities in Myanmar. BMC Res Notes. 2017 Feb 15;10(1):99. doi: 10.1186/s13104-017-2422-2.

    PMID: 28202069BACKGROUND
  • Bjertness MB, Htet AS, Meyer HE, Htike MM, Zaw KK, Oo WM, Latt TS, Sherpa LY, Bjertness E. Prevalence and determinants of hypertension in Myanmar - a nationwide cross-sectional study. BMC Public Health. 2016 Jul 18;16:590. doi: 10.1186/s12889-016-3275-7.

    PMID: 27430560BACKGROUND
  • GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.

    PMID: 33069326BACKGROUND
  • Ansbro E, Issa R, Willis R, Blanchet K, Perel P, Roberts B. Chronic NCD care in crises: A qualitative study of global experts' perspectives on models of care for hypertension and diabetes in humanitarian settings. J Migr Health. 2022 Mar 24;5:100094. doi: 10.1016/j.jmh.2022.100094. eCollection 2022.

    PMID: 35434681BACKGROUND
  • Jaung MS, Willis R, Sharma P, Aebischer Perone S, Frederiksen S, Truppa C, Roberts B, Perel P, Blanchet K, Ansbro E. Models of care for patients with hypertension and diabetes in humanitarian crises: a systematic review. Health Policy Plan. 2021 May 17;36(4):509-532. doi: 10.1093/heapol/czab007.

    PMID: 33693657BACKGROUND
  • Ansbro E, Homan T, Qasem J, Bil K, Rasoul Tarawneh M, Roberts B, Perel P, Jobanputra K. MSF experiences of providing multidisciplinary primary level NCD care for Syrian refugees and the host population in Jordan: an implementation study guided by the RE-AIM framework. BMC Health Serv Res. 2021 Apr 26;21(1):381. doi: 10.1186/s12913-021-06333-3.

    PMID: 33896418BACKGROUND
  • Ruby A, Knight A, Perel P, Blanchet K, Roberts B. The Effectiveness of Interventions for Non-Communicable Diseases in Humanitarian Crises: A Systematic Review. PLoS One. 2015 Sep 25;10(9):e0138303. doi: 10.1371/journal.pone.0138303. eCollection 2015.

    PMID: 26406317BACKGROUND
  • Wagstaff A. The bounds of the concentration index when the variable of interest is binary, with an application to immunization inequality. Health Econ. 2005 Apr;14(4):429-32. doi: 10.1002/hec.953.

    PMID: 15495147BACKGROUND
  • Tiberti M, Costa V. Disability Measurement in Household Surveys : A Guidebook for Designing Household Survey Questionnaires (English) Washington, D.C.: World Bank Group, 2020.

    BACKGROUND

MeSH Terms

Conditions

Cardiovascular DiseasesHypertensionDiabetes Mellitus

Interventions

Community Health Workers

Condition Hierarchy (Ancestors)

Vascular DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Allied Health PersonnelHealth PersonnelHealth Care Facilities Workforce and Services

Study Officials

  • Adam Richards

    George Washington University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Cluster Randomized Controlled Trial in 13 villages
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 25, 2025

First Posted

February 11, 2025

Study Start

October 27, 2024

Primary Completion

April 30, 2025

Study Completion

June 30, 2025

Last Updated

July 31, 2025

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations